Please login to the form below

Not currently logged in
Email:
Password:

HeartCel

This page shows the latest HeartCel news and features for those working in and with pharma, biotech and healthcare.

Celixir cleared to start trial of stem cell therapy for heart failure

Celixir cleared to start trial of stem cell therapy for heart failure

Previous trial demonstrated patients achieving 100% MACE free survival. UK biotech Celixir has been given a green light to start a phase IIb trial of HeartCel - its stem cell-based therapy ... The initial Heartcel trial results are very exciting, showing

Latest news

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    Additional undisclosed payments will also be forthcoming if HeartCel passes other development and regulatory milestones, as well as royalties on any future sales. ... HeartCel has been clinically tested with heart failure patients who undergo bypass

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...